The Concept of Clinically Meaningful Difference in Health-Related Quality-of-Life Research Ron D. HaysJ. Michael Woolley Current Opinion 23 December 2012 Pages: 419 - 423
HIV-1 Drug Resistance Genotyping Carine Chaix-CouturierChristopher HoltzerJohn Stansell Review Article 23 December 2012 Pages: 425 - 433
Health-Related Quality-of-Life Measurement in Hypertension Isabelle CôtéJean-Pierre GrégoireJocelyne Moisan Review Article 23 December 2012 Pages: 435 - 450
Cost Analysis of an Adult Outpatient Parenteral Antibiotic Therapy (OPAT) Programme Amy O. WaiLuciana FrighettoPeter J. Jewesson Original Research Article 23 December 2012 Pages: 451 - 457
Economic Impact of Increased Clinical Intervention Rates in Community Pharmacy Shalom I. BenrimojJane H. LangfordMatthew Dobson Original Research Article 23 December 2012 Pages: 459 - 468
Cost-Effectiveness Analysis of Topical Calcipotriol versus Short- Contact Dithranol Darren M. AshcroftAlain Li Wan PoChristopher E. M. Griffiths Original Research Article 23 December 2012 Pages: 469 - 476
Economic Impact of Tibolone Compared with Continuous-Combined Hormone Replacement Therapy Jonathan M. PlumbJulian F. Guest Original Research Article 23 December 2012 Pages: 477 - 486
Inhaled Fluticasone Propionate Harriet M. LambChristine R. CulyDiana Faulds Adis Pharmacoeconomic Drug Evaluation 23 December 2012 Pages: 487 - 510
Economic Analysis of Long Term Reversible Contraceptives Pekka Rissanen Correspondence 23 December 2012 Pages: 511 - 511
Economic Analysis of Long Term Reversible Contraceptives Ceri J. Phillips Correspondence 23 December 2012 Pages: 511 - 512